logo-loader
viewZoono Group Ltd

Zoono Group finding a 'new and different space' for antibacterial products globally

Zoono Group Ltd (ASX:ZNO) managing director & CEO Paul Hyslop introduces Proactive Investors to the global biotech player in long-lasting antibacterials. The company's technology is designed for use on skin, fabric, and hard surfaces.

Zoono currently has a range of more than 14 consumer products with more in the pipeline; and a number of recently-announced international distribution deals with more under negotiation.

Hyslop says, "We are heading towards substantial revenues in the coming 12 to 24 months."

Quick facts: Zoono Group Ltd

Price: 0.24 AUD

ASX:ZNO
Market: ASX
Market Cap: $39.2 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Piedmont Lithium secures landmark Section 404 Permit to...

Piedmont Lithium Ltd (ASX:PLL) CEO Keith Phillips tells Proactive the lithium explorer has received the Section 404 Permit under the Clean Water Act from the US Army Corps of Engineers for its lithium project in North Carolina. Phillips says this landmark achievement follows a fair, albeit...

10 hours, 53 minutes ago

2 min read